Coptis, Pinellia, and Scutellaria as a promising new drug combination for treatment of Helicobacter pylori infection

doi:10.12998/wjcc.v10.i34.12500

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3996)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

198

WORD

HTML

2411

Figures (1-4)

326

Tables (1-4)

316

Sum=3283

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

203

Download

510

Sum=713

Dec 6, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Dec 6, 2022; 10(34): 12500-12514
Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12500

Table 4 Information on compounds in Coptis, Pinellia, and Scutellaria

Herb	Compounds
Coptidis Rhizoma	Berberine; Berberrubine; (R)-Canadine; Berlambine; Worenine; Coptisine; Epiberberine
Pinelliae Rhizoma	Coniferin; Cavidine; Cycloartenol; Gondoic acid; 24-Ethylcholest-4-en-3-one; 10,13-eicosadienoic; Baicalein; Beta-sitosterol; Stigmasterol
Scutellariae Radix	Acacetin; Wogonin; Rivularin; Salvigenin; Norwogonin; Panicolin; Sitosterol; Oroxylina; Skullcapflavone II; Neobaicalein; Moslosooflavone; 11,13-Eicosadienoic acid; Methyl ester; Dihydrooroxylin A; Dihydrobaicalin_qt; 5,2‘,6’-Trihydroxy-7,8-dimethoxyflavone; 5,8,2‘-Trihydroxy-7-methoxyflavone; Dihydrooroxylin; (2R)-7-hydroxy-5-methoxy-2-phenylchroman-4-one; Tenaxin I; Coptisine; Epiberberine; Baicalein; Beta-sitosterol; Stigmasterol

Citation: Yu Z, Sheng WD, Yin X, Bin Y. Coptis, Pinellia, and Scutellaria as a promising new drug combination for treatment of Helicobacter pylori infection . World J Clin Cases 2022; 10(34): 12500-12514
URL: https://www.wjgnet.com/2307-8960/full/v10/i34/12500.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i34.12500